Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 16,072 | 3,267 | 9,247 | 8,153 | 7,557 |
| Gross Profit | 16,072 | 3,267 | 9,247 | 8,153 | 7,557 |
| Operating Expenses | 24,877 | 24,840 | 33,125 | 26,654 | 28,654 |
| Operating Income | -8,805 | -21,573 | -23,878 | -18,501 | -21,097 |
| Other Income | 1,614 | 1,698 | 2,214 | 2,652 | 3,161 |
| Pre-tax Income | -7,191 | -19,875 | -21,664 | -15,849 | -17,936 |
| Net Income Continuous | -7,191 | -19,875 | -21,664 | -15,849 | -17,936 |
| Net Income | $-7,191 | $-19,875 | $-21,664 | $-15,849 | $-17,936 |
| EPS Basic Total Ops | -0.10 | -0.29 | -0.35 | -0.25 | -0.28 |
| EPS Basic Continuous Ops | -0.10 | -0.29 | -0.34 | -0.25 | -0.28 |
| EPS Diluted Total Ops | -0.10 | -0.29 | -0.35 | -0.25 | -0.28 |
| EPS Diluted Continuous Ops | -0.10 | -0.29 | -0.34 | -0.25 | -0.28 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.29 | -0.34 | -0.25 | -0.28 |
| EBITDA(a) | $-9,193 | $-21,723 | $-23,382 | $-18,005 | $-20,692 |